Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NKCC1 inhibitors(Solute carrier family 12 member 2 inhibitors), NKCC2 inhibitors(Sodium-(potassium)-chloride cotransporter 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Edema | Phase 2 | CN | 01 Sep 2023 | |
Cerebral Hemorrhage | Phase 2 | CN | 01 Sep 2023 | |
Encephalocele | Phase 2 | CN | 01 Sep 2023 | |
Asthma | Preclinical | CN | 26 Apr 2023 | |
Pulmonary Edema | Preclinical | CN | 26 Apr 2023 |